R. Stupp, M. Hegi, and W. Mason, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

R. Stupp, S. Taillibert, and A. Kanner, Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma, JAMA, vol.314, issue.23, pp.2535-2543, 2015.
DOI : 10.1001/jama.2015.16669
URL : http://jama.jamanetwork.com/data/journals/jama/934761/jpc150007.pdf

J. Lathia, S. Mack, E. Mulkearns-hubert, C. Valentim, and J. Rich, Cancer stem cells in glioblastoma, Genes & Development, vol.29, issue.12, pp.1203-1217, 2015.
DOI : 10.1101/gad.261982.115

J. Hale, M. Sinyuk, J. Rich, and J. Lathia, Decoding the cancer stem cell hypothesis in glioblastoma, CNS Oncology, vol.28, issue.4, pp.319-330, 2013.
DOI : 10.1002/stem.542
URL : http://europepmc.org/articles/pmc3873749?pdf=render

K. Yan, K. Yang, and J. Rich, The evolving landscape of glioblastoma stem cells, Current Opinion in Neurology, vol.26, issue.6, pp.701-707, 2013.
DOI : 10.1097/WCO.0000000000000032
URL : http://europepmc.org/articles/pmc4031658?pdf=render

C. Calabrese, H. Poppleton, and M. Kocak, A Perivascular Niche for Brain Tumor Stem Cells, Cancer Cell, vol.11, issue.1, pp.69-82, 2007.
DOI : 10.1016/j.ccr.2006.11.020
URL : https://doi.org/10.1016/j.ccr.2006.11.020

E. Galan-moya, L. Guelte, A. , L. Fernandes, and E. , Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway, EMBO reports, vol.19, issue.5, pp.470-476, 2011.
DOI : 10.1038/sj.onc.1208311
URL : http://embor.embopress.org/content/embor/12/5/470.full.pdf

K. Jacobs, E. Harford-wright, and J. Gavard, Neutralizing gp130 interferes with endothelial-mediated effects on glioblastoma stem-like cells, Cell Death & Differentiation, vol.24, issue.2, p.384, 2017.
DOI : 10.1371/journal.pone.0093505
URL : https://hal.archives-ouvertes.fr/inserm-01444543

X. Jin, L. Kim, and Q. Wu, Targeting glioma stem cells through combined BMI1 and EZH2 inhibition, Nature Medicine, vol.335, pp.1352-1361, 2017.
DOI : 10.1016/j.jns.2013.09.030
URL : http://europepmc.org/articles/pmc5679732?pdf=render

B. Ding, D. Nolan, and J. Butler, Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration, Nature, vol.22, issue.7321, pp.310-315, 2010.
DOI : 10.1038/nature09493
URL : http://europepmc.org/articles/pmc3058628?pdf=render

Z. Cao, T. Ye, and Y. Sun, Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis, Science Translational Medicine, vol.125, issue.405, p.8710, 2017.
DOI : 10.1152/ajplung.00026.2010
URL : http://europepmc.org/articles/pmc5606244?pdf=render

L. Treps, S. Edmond, and E. Harford-wright, Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma, Oncogene, vol.119, issue.20, pp.2615-2623, 2016.
DOI : 10.1038/ncomms7999
URL : https://hal.archives-ouvertes.fr/inserm-01406334

L. Guelte, A. Galan-moya, E. Dwyer, and J. , Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation, Journal of Cell Science, vol.119, issue.17, pp.4137-4146, 2012.
DOI : 10.1038/sj.onc.1208311
URL : https://hal.archives-ouvertes.fr/hal-01541442

S. Pitkin, J. Maguire, R. Kuc, and A. Davenport, Modulation of the apelin/APJ system in heart failure and atherosclerosis in man, British Journal of Pharmacology, vol.30, issue.7, pp.1785-1795, 2010.
DOI : 10.1016/j.peptides.2009.02.010

R. Kalin, M. Kretz, A. Meyer, A. Kispert, F. Heppner et al., Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis, Developmental Biology, vol.305, issue.2, pp.599-614, 2007.
DOI : 10.1016/j.ydbio.2007.03.004

N. Macaluso, S. Pitkin, J. Maguire, A. Davenport, and R. Glen, Discovery of a Competitive Apelin Receptor (APJ) Antagonist, ChemMedChem, vol.306, issue.6, pp.1017-1023, 2011.
DOI : 10.1038/sj.bjp.0703939

A. Zhou, K. Lin, and S. Zhang, Nuclear GSK3?? promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22, Nature Cell Biology, vol.1280, issue.9, pp.954-966, 2016.
DOI : 10.1038/nature737
URL : http://europepmc.org/articles/pmc5026327?pdf=render

L. Zuurbier, A. Rahman, and M. Cordes, Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer, Oncotarget, vol.8, issue.26, pp.42949-42961, 2017.
DOI : 10.18632/oncotarget.17306
URL : http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=17306&path%5B%5D=59130

J. Berta, I. Kenessey, and J. Dobos, Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis, Journal of Thoracic Oncology, vol.5, issue.8, pp.1120-1129, 2010.
DOI : 10.1097/JTO.0b013e3181e2c1ff
URL : https://doi.org/10.1097/jto.0b013e3181e2c1ff

S. Azzi, J. Hebda, and J. Gavard, Vascular Permeability and Drug Delivery in Cancers, Frontiers in Oncology, vol.3, p.211, 2013.
DOI : 10.3389/fonc.2013.00211
URL : https://www.frontiersin.org/articles/10.3389/fonc.2013.00211/pdf

S. Patel, N. Sanjana, and R. Kishton, Identification of essential genes for cancer immunotherapy, Nature, vol.3, issue.7669, pp.537-542, 2017.
DOI : 10.1038/ncomms1893
URL : https://www.nature.com/articles/nature23477.pdf